Related Resources
®Clinical Utility Index (CUI) Analysis — Selected References
Journal Articles
Poland B, Hodge FL, Khan A, Clemen RT, Wagner JA, Dykstra K, Krishna R. The Clinical Utility Index as a Practical Multiattribute Approach to Drug Development Decisions. Clin Pharmacol Ther advance online publication, May 20, 2009; doi:10.1038/clpt.2009.71.
Korsan B, Dykstra K, Pullman W. Transparent Trade-Offs: A Clinical Utility Index (CUI) Openly Evaluates a Product's Attributes — and Chance of Success. Pharmaceutical Executive. March 2005.
Presentations and Posters
Carrothers TJ. The Clinical Utility Index, a Method for Balancing Efficacy and Safety in Drug Development Decision-Making. [invited presentation]. Presented at: Pacific Coast Statisticians & Pharmacometricians Innovation Conference (PaSiPhIC); June 14-16, 2010; San Luis Obispo, CA.
Hodge FL. Using the Clinical Utility Index (CUI) to Inform Dose Selection Decisions: Integrated Modeling and Simulation Approach in Alzheimer's Disease. Pharsight Webinar; February 4, 2009.
Dykstra K, Hodge L, Carrothers TJ, Korsan B. Linking Modeling & Simulation, Decision Analysis, and the Technology of Drug Formulation. [poster #67]. American Conference on Pharmacometrics (ACoP); March 9-12, 2008; Tucson, Arizona.